STAGE IIIC CUTANEOUS MELANOMA AJCC V7
Clinical trials for STAGE IIIC CUTANEOUS MELANOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC CUTANEOUS MELANOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIC CUTANEOUS MELANOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise in small melanoma trial
Disease control CompletedThis early-phase trial tested the safety and effectiveness of combining two drugs—imiquimod (a cream that stimulates the immune system) and pembrolizumab (an immunotherapy injection)—in 7 patients with advanced melanoma that had spread. The goal was to see if the combination coul…
Matched conditions: STAGE IIIC CUTANEOUS MELANOMA AJCC V7
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New combo shows promise against tough skin cancer
Disease control CompletedThis study tested whether adding bevacizumab to ipilimumab helps people with advanced melanoma (skin cancer that has spread and cannot be removed by surgery). A total of 169 patients took part. The goal was to see if the combination improves overall survival and slows cancer grow…
Matched conditions: STAGE IIIC CUTANEOUS MELANOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC